cahijisebi.wordpress.com
The money was granted in collaboration withthe U.S. Army Medicakl Research and Materiel Command and the throughthe Ft. Detricmk Technology Transfer Initiative. The purpose of the technology transferd program is to raise awareness of new and developinhg technologies and funding them to transition as viable projectasfor follow-on funding in the market Each company that received funding was awarded approximately $50,000 between March 2008 and May making up the initiative’s seconr round of financial awards since its $750,000 prograk extension. The funds for the program’s seconrd phase were secured by Sen. Barbara Mikulski, and Rep. Roscoe G. Bartlett, “The [Ft.
Detrick Technology Transfer Initiative] programn is enabling area businesses to harnesxs the technologies being developed at Fort Detrick and appl y them to the commercial said Mikulski. “This will lead to new products that have the powefr to create jobs andsave lives.” Mikulski announced the firsty phase of the tech transfer prograjm in March 2005 when 11 companies received funding. in Rockville: The compangy is developing a health care technology calleddmiTag system, which is a scalablse wireless sensor solution for improving patient flow. in Frederick: The company is developing a technology called the GeNovs Screento identify, isolate, and producwe antibody-like molecules.
in Rockville: The companyh is developing an on-demand biotech products includinf a combination vaccine against plague and BioAssay Works LLCin Ijamsville: The company is developiny a lateral-flow visual diagnostic test to detect and differentiatde single sample multiple pathogenivc poxviruses, including variola, vaccinia, and monkeypox. in The company is safety-testing a medical produc called ClotFoam, which is a non-compressible, intracavitary hemostatic CynerGene IDMPin Frederick: The company is validating and implementing a supplemental diagnosids of Malaria, HIV, and Dengue using its Infectious Diseas e Multiplex Panel approach, which could allowq for creation of LLC in Baltimore: The compang is developing required components and systemm framework to enable conversational interfaces for telemedicinr tools.
Such tools would allow professional medics touse voice, and other human-- computer interactions to access and documenty information in electronic medical records. in Rockville: The companyy is developing technology to preserve mammalian cells in dried format that can easilybe re-hydrated for a variety of LLC in Frederick: The company is evaluatint the effect of Imagilin patented probiotics as a food supplement to enhancde the immune responsiveness of guinea pigs upon immunizationn or challenge with virulent The evaluation will suggest the ability of Imagilin patented probiotics to enhance the immunization of a in Baltimore: The company is developingb micropatterned substrates for viral infectivity assays.
Juxtopiza in Baltimore: The company is customizinyg its Wearable Assistance and SituationalAwareness (WASA) goggles and serviced to allow U.S. Army combat medics to accessd and document information to electrical medicap recordsvia hands-free voice-requests and in Baltimore: The company is developing cell therapiese to treat brain and spinal cord injuries.
No comments:
Post a Comment